The International Angelman Syndrome Research Council (INSYNC-AS) held its first meeting virtually, as a joint project of the Foundation for Angelman Syndrome Therapeutics (FAST) and the Simons Foundation Autism Research Initiative (SFARI). The meeting brought together experts with preclinical, clinical, regulatory and industry perspectives to discuss new ways to accelerate translational research related to treatments for Angelman syndrome (AS) and other neurodevelopmental disorders (NDDs).
Read this meeting report at SFARI.org.
Michele Solis 
The International Angelman Syndrome Research Council (INSYNC-AS) held its first meeting virtually, as a joint project of the Foundation for Angelman Syndrome Therapeutics (FAST) and the Simons Foundation Autism Research Initiative (SFARI). The meeting brought together experts with preclinical, clinical, regulatory and industry perspectives to discuss new ways to accelerate translational research related to treatments for Angelman syndrome (AS) and other neurodevelopmental disorders (NDDs).
Read this meeting report at SFARI.org.
Share this: